{
  "catalogId": "6f5cbf5e-40f5-41ac-9785-719c0ba48b6b",
  "name": "CARDIOXANE",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "109 84 29292 00",
  "treatmentDescriptions": "Prevention of cardiotoxicity in adult women with advanced and/or metastatic  breast cancer at high risk of heart failure who have received a prior cumulative dose of 300 mg/m2 of doxorubicin or a prior cumulative dose of 540 mg/m2 of epirubicin when further anthracycline treatment is required.",
  "termsOfIssue": "Prescription required",
  "form": "powder for solution for infusion",
  "route": "i.v",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "DEXRAZOXANE AS HYDROCHLORIDE/VIAL",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "V03AF02",
      "name": "DEXRAZOXANE"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "CARDIOXANE 500MG VIAL PWDR FOR INFUS",
      "manufacturer": {
        "name": "מגאפארם",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 1.0,
        "unit": "units"
      },
      "packagingDescription": "VIAL GLASS TYPE I",
      "shelfLife": "36",
      "storageConditions": "",
      "codes": {
        "moh": "4051",
        "yarpa": "26704",
        "pharmasoft": "3698"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 685.5089323,
        "retailMargin": 17.5,
        "maxRetailPrice": 805.4729955,
        "maxPriceWithVAT": 950.4580924
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-08-01T12:18:43.572260"
  }
}